Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.
Subcutaneous implantable cardioverter defibrillators (S‐ICDs) provide reliable defibrillation and have enhanced supraventricular tachycardia discrimination and fewer infection rates compared with traditional transvenous systems. However, inappropriate shocks remain a frequent problem. Herein, we rev...
| Publicado en: | Journal of Cardiovascular Electrophysiology Vol. 30; no. 3; pp. 402 - 410 |
|---|---|
| Autores principales: | , , |
| Formato: | algorithm review tables/charts tracings Journal Article |
| Publicado: |
Wiley-Blackwell
Mar2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135402871&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 135402871 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10453873 GSB jtl: Journal of Cardiovascular Electrophysiology issn: 10453873 maglogo: Y pubinfo: dt: Mar2019 vid: 30 iid: 3 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 135402871 135402871 135402871 10.1111/jce.13831 135402871 ppf: 402 ppct: 8 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators. aug: au: Karnik, Ankur A. Helm, Robert H. Monahan, Kevin M. affil: Electrophysiology and Arrhythmia Service, Cardiology Division, Department of Medicine, Boston Medical Center, Boston Massachusetts sug: subj: Treatment Errors Prevention and Control Defibrillators, Implantable Defibrillation Tachycardia, Supraventricular Algorithms Recurrence Prevention and Control Preimplantation Diagnosis Health Screening Cardiomyopathy, Hypertrophic Therapy Brugada Syndrome Therapy Arrhythmogenic Right Ventricular Dysplasia Therapy ab: Subcutaneous implantable cardioverter defibrillators (S‐ICDs) provide reliable defibrillation and have enhanced supraventricular tachycardia discrimination and fewer infection rates compared with traditional transvenous systems. However, inappropriate shocks remain a frequent problem. Herein, we review the various mechanisms of these inappropriate therapies, some of which are unique to S‐ICDs, and propose an algorithm for preventing recurrences. Proper screening of preimplants is essential to help minimize inappropriate therapies, but patients with hypertrophic cardiomyopathy, Brugada syndrome, and arrhythmogenic right ventricular cardiomyopathy are at particular risk and may require additional measures. pubtype: Academic Journal doctype: algorithm review tables/charts tracings Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|